Business
ImmunoGen to Slash Payroll: ImmunoGen Inc. said it will lay off 100 of its 180 employees, or about 60% of its work force, and cut senior management salaries 20% to reduce expenses.
Dec. 20, 1994
Shares of EntreMed Inc., OSI Pharmaceuticals Inc. and ImmunoGen Inc. tumbled Monday after the biotechnology companies presented research showing smaller benefits than investors hoped to see from their experimental cancer drugs.
May 15, 2001
California
A private appeal from the archbishop of Los Angeles for the archdiocese’s 2,900 nuns and priests to volunteer for tests of an experimental AIDS vaccine developed by Dr.
March 12, 1990
Science & Medicine
An AIDS immunization treatment developed by Dr.
June 9, 1989
A Food and Drug Administration advisory panel, despite much skepticism from its scientist members, has recommended that a Southern California biotechnology company be allowed to go ahead with widespread human clinical tests of the first therapeutic vaccine for AIDS.
Jan. 28, 1995
International Genetic Engineering Inc. said it has been issued a U.S. patent on a class of proteins named regressens--antigens associated with tumor regression.
June 24, 1988
Mary Arthur celebrated a milestone this year.
April 4, 1993
Lidak Shares Up 4.6%: The stock price jump came after La Jolla-based Lidak Pharmaceuticals said it had received Food and Drug Administration approval to begin human tests of a potential skin cancer therapy.
Aug. 24, 1995
A highly toxic cancer drug linked to antibodies and directed against a protein on the surface of cancer cells can completely eradicate human colon tumors grown in mice without producing adverse side effects, researchers from ImmunoGen Inc. reported in the Aug. 6 Proceedings of the National Academy of Sciences.
Aug. 8, 1996
At the Sixth International Conference on AIDS, new data was presented on many experimental therapies.
June 25, 1990